Previous 10 | Next 10 |
The Global Communications Leader, Who Previously Held Roles at Aurora, Tesla, Nike, and Square, Will Strengthen and Elevate the Rapidly Growing Health and Wellness Brand Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform,...
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023. The company will host a live conference call to discu...
2023-10-03 05:35:00 ET Share prices of direct-to-consumer healthcare company Hims & Hers Health (NYSE: HIMS) started hot in 2023, doubling from $6 per share to $12. But the stock has lost momentum, drifting backward since peaking, and is now flat for the year. Was the early...
2023-09-27 06:01:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some companies stand out as genuine contenders for explosive growth and substantial gains in the stock market. The article lists three s tocks to buy now that have thrived thanks to their i...
2023-09-25 08:30:00 ET Summary Hims & Hers Health has found itself in the center of a short seller's reticle lately, which may be contributing to the malaise in its share price. But while the short seller may find Hims & Hers Health's business unattractive, the reality has...
2023-09-22 06:00:00 ET Fool.com contributor Parkev Tatevosian analyzes Hims and Hers (NYSE: HIMS) stock to answer if it makes an excellent buy at current valuations. *Stock prices used were the afternoon prices of Sept. 19, 2023. The video was published on Sept. 21, 2023. ...
2023-09-20 23:55:13 ET Summary Hims & Hers reported strong earnings and raised its full-year guidance, but its stock continues to decline. Hims & Hers is focusing on personalization and expanding into new categories to drive growth. While the risks are evident, the com...
2023-09-20 10:46:15 ET Summary Hims & Hers Health, Inc. is rapidly growing and becoming more profitable, making it a cheaply valued stock with minimal risk. A recent short report questions Hims' ability to turn customer acquisition into profitability, but recent financial data...
2023-09-17 23:00:13 ET Summary Hims & Hers managed to grow revenue every year by at least 80%. However, it's still trading below its initial price when became publicly traded via SPAC. The company is targeting lofty growth targets for years to come and has plans to expand in m...
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List . The Best Workplaces in H...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
--News Direct-- The telemedicine market is not just growing; it's booming. Valued at USD 97.48 billion in 2022 and projected to surge to USD 430.72 billion by 2031, with a robust CAGR of 17.95%, telemedicine is revolutionizing healthcare delivery worldwide. This industry uses telecommunicatio...
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...